The updated AHA/ACC cholesterol management guidelines recommend moderate or high intensity statin therapy in patients over 75 years old with clinical atherosclerotic cardiovascular disease. According ...
In a huge setback a study has found that the Simvastatin-Ezetimibe reduces risk of coronary artery disease (CAD), but does not slow its progression. The Simvastatin and Ezetimibe in Aortic Stenosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results